Drugs / Neuroblastoma Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01192555 | Sep 2010 → Jul 2012 overdue | neuroblastoma | Baylor College of Medicine | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neuroblastoma Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01192555 ↗ |
| Action | Deplete | “the vaccine will cause the immune system to recognize and kill more types of neuroblastoma tumors” NCT01192555 ↗ |
| Modality | Vaccine | “tumor vaccine” NCT01192555 ↗ |
| Route | Subcutaneous | “given by subcutaneous injection” NCT01192555 ↗ |